Skip to main content
# Title Research Member Research Year
1 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2025
2 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Dr. Shimaa Hassan Shabaan Hassan 2025
3 The prognostic impact of PBRM1 immunohistochemical expression and its association with CD3+ and CD8+ immune cells in patients with renal cell carcinoma: A retrospective study Amira Emad Mohamed Elwy 2025
4 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Amira Emad Mohamed Elwy 2024
5 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2024
6 Prognostic significance of CD3+ and CD8+ T-cells immunoscore in renal cell carcinoma: A comparison between two simple models for assessment Dr. Shimaa Hassan Shabaan Hassan 2024
7 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Israa Mostafa Kamal Mohammed 2022
8 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Dr. Marwa Tammam Ameen Hammam 2022
9 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Dr. Hanaan Ahmed Mohammed Ahmed 2022
10 Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients Prof. Eman Massad Zaki El-Hefny 2022